Patent ID: 11958856
Assignee: JANSSEN PHARMACEUTICA NV
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The compound of claim 1, or a pharmaceutically acceptable salt or stereoisomer thereof, wherein:
R1 is halogen, C1-4 alkyl, C1-2 fluoroalkyl, OH, OC1-4 alkyl, OC1-2 fluoroalkyl, C3-6 cycloalkyl, phenyl, or 5- or 6-membered heterocyclyl, wherein the C3-6 cycloalkyl, phenyl, or 5- or 6-membered heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of halogen, C1-4 alkyl, C1-2 fluoroalkyl, C(O)OH, C(O)OC1-4 alkyl, OH, OC1-4 alkyl, and OC1-2 fluoroalkyl;
R6 is phenyl or 9- or 10-membered heteroaryl, wherein the phenyl or 9- or 10-membered heteroaryl is optionally substituted with one or two substituents independently selected from the group consisting of halogen, C1-4 alkyl, C1-2 fluoroalkyl, C1-2 hydroxyalkyl, C(O)NRERF, C(O)OH, and C(O)OC1-4 alkyl;
each RE is independently H or C1-2 alkyl;
each RF is independently H or C1-2 alkyl; and
a is 0, 1, or 2.